Table 4.

Results of univariate logistic regression analysis and receiver operating characteristic curves for the risk of liver failure according to the ISGLS criteria

	Odds ratio (95% CI)	p value	AUC (95% CI)	p value
Established clinical variable
PDR	0.91 (0.82–1.01)	0.073	0.647 (0.51–0.783)	0.082
R15	1.13 (0.94–1.34)	0.190	0.350 (0.216–0.484)	0.075
Established MDCT variables
FLR, ml	0.996 (0.994–0.999)	0.015*	0.736 (0.59–0.883)	0.005*
Proportion of FLR, %	0.906 (0.847–0.969)	0.004*	0.808 (0.692–0.924)	< 0.001*
Weight-adapted FLR, ml/kg	0.602 (0.430–0.843)	0.003*	0.825 (0.714–0.935)	< 0.001*
Established gadoxetic acid enhanced variable
remnantRLE	0.029 (0.003–0.282)	0.002*	0.729 (0.672–0.912)	0.001*
Functional volume
functFLR, ml/kg	0.994 (0.991–0.998)	0.002*	0.904 (0.803–0.977)	<0.001*

CI confidence interval, AUC area under the curve, PDR plasma disappearance rate, R15 median retention rate at 15 min, MDCT multidetector CT, FLR future liver remnant, remnantRLE mean relative enhancement of the FLR, functFLR functional future liver remnant

*Significant difference